Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Top Cited Papers
- 24 June 2002
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (8), 793-800
- https://doi.org/10.1038/nm730
Abstract
B7-H1, a recently described member of the B7 family of costimulatory molecules, is thought to be involved in the regulation of cellular and humoral immune responses through the PD-1 receptor on activated T and B cells. We report here that, except for cells of the macrophage lineage, normal human tissues do not express B7-H1. In contrast, B7-H1 is abundant in human carcinomas of lung, ovary and colon and in melanomas. The pro-inflammatory cytokine interferon-γ upregulates B7-H1 on the surface of tumor cell lines. Cancer cell–associated B7-H1 increases apoptosis of antigen-specific human T-cell clones in vitro, and the apoptotic effect of B7-H1 is mediated largely by one or more receptors other than PD-1. In addition, expression of B7-H1 on mouse P815 tumor increases apoptosis of activated tumor-reactive T cells and promotes the growth of highly immunogenic B7-1+ tumors in vivo. These findings have implications for the design of T cell–based cancer immunotherapy.Keywords
This publication has 35 references indexed in Scilit:
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- T cell co-stimulatory molecules other than CD28Current Opinion in Immunology, 1999
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.The Journal of Experimental Medicine, 1996
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.The Journal of Experimental Medicine, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993